DCF — ST ALOISIUS MEDICAL CENTER
Enterprise Value: $-16.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-16.0M
Enterprise Value
$-5.5M
PV of Cash Flows
$-10.5M
PV of Terminal Value
$-16.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $22.5M | $-0.8M | -3.0% | $-1.7M | $-1.6M |
| Year 2 | $23.2M | $-0.6M | -2.0% | $-1.5M | $-1.3M |
| Year 3 | $23.9M | $-0.3M | -1.0% | $-1.3M | $-1.0M |
| Year 4 | $24.6M | $-0.2M | -1.0% | $-1.3M | $-0.9M |
| Year 5 | $25.3M | $-0.2M | -1.0% | $-1.2M | $-0.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-16.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$21.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0389562183185506
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5